SIP
ARRY

Stoneridge Investment Partners’s Array Biopharma Inc ARRY Stock Holding History

Stoneridge Investment Partners’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-51,452
Closed -$234K – 240
2013
Q2 		$234K Buy
+51,452
New +$277K 0.05% 159

Other funds holding ARRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stoneridge Investment Partners's ARRY Position: Q3 2013 in Review

Stoneridge Investment Partners sold out of Array Biopharma Inc (ARRY) in Q3 2013, closing a stake of 51,452 shares — an estimated $234K sold.

Stoneridge Investment Partners first reported a position in ARRY in Q2 2013 and held it in 1 quarter. The position peaked at $234K in Q2 2013. 134 funds tracked by Wall St. Rank hold ARRY as of Q3 2013.

  • Stoneridge Investment Partners reported no remaining Array Biopharma Inc position as of Q3 2013 after selling out during the quarter.
  • Stoneridge Investment Partners sold 51,452 Array Biopharma Inc shares in Q3 2013, an estimated $234K.
  • Stoneridge Investment Partners first reported a position in Array Biopharma Inc in Q2 2013 and held it in 1 quarter.
  • Stoneridge Investment Partners's Array Biopharma Inc position peaked at $234K in Q2 2013.
  • 134 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2013.

Based on Stoneridge Investment Partners's 13F filing for Q3 2013, filed 15 Oct 2013.